Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | PRJ1-3024 |
Trade Name | |
Synonyms | PRJ1 3024|PRJ13024 |
Drug Descriptions |
PRJ1-3024 inhibits Hpk1 (Map4k1), which may reduce immunosuppression in the tumor microenvironment and result in induction of a cytotoxic T-lymphocyte (CTL) response against tumor cells (NCI Drug Dictionary). |
DrugClasses | MAP4K1 Inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | C185859 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PRJ1-3024 | PRJ1-3024 | 0 | 1 |